Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Mayo Fecal Stability Study II

PROVIDER: PRJEB13895 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR1403170.fastq.gz	Fastqsanger.gz
	ERR1403180.fastq.gz	Fastqsanger.gz
	ERR1403190.fastq.gz	Fastqsanger.gz
	ERR1403200.fastq.gz	Fastqsanger.gz
	ERR1403210.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 962

Similar Datasets

Project description:Mayo Fecal Stability Study I

| PRJEB13940 | ENA

Project description:Mayo Fecal Stability II saliva only

| PRJEB13898 | ENA

PGRN-RIKEN Mayo-NSABP Prevention Study

Project description:PGRN-RIKEN Mayo-NSABP Prevention Study

| PRJNA75693 | ENA

Homo sapiens

Project description:PGRN-RIKEN Mayo-NSABP Prevention Study

| PRJNA75695 | ENA

NHLBI TOPMed: Mayo Clinic Venous Thromboembolism (VTE) Study

Project description:NHLBI TOPMed: Mayo Clinic Venous Thromboembolism (VTE) Study

| PRJNA393376 | ENA

Homo sapiens

Project description:NHLBI TOPMed: Mayo Clinic Venous Thromboembolism (VTE) Study

| PRJNA393377 | ENA

Project description:Temporal variability and stability of the fecal microbiome: the Multiethnic Cohort Study

| PRJNA481072 | ENA

Gene Expression Profiling of Surgically Resectable Soft-Tissue Sarcomas

Project description:For the current study we performed whole genome expression profiling on 69 unique patients with soft-tissue sarcoma who underwent curative-intent surgical resection to identify prognostic gene signatures. Specimens were obtained from the Mayo Clinic Florida STS Biobank and RNA was sequenced using the Tempus xT RNA-seq protocol. This protocol uses transcriptome-capture via more than 415,000 IDT xGen probes spanning greater than 19,000 genes, with at least 50 ng of extracted RNA required before proceeding to library preparation and a minimum depth of 30 million reads a on a NovaSeq 6000. RNA-seq data was analyzed using the MAP-RSeq pipeline developed by Mayo Clinic Bioinformatics Shared Resource.

2023-06-05 | GSE234092 | GEO

Effect of morphine treatment on microbiome in the context of microbial transplant.

Project description:Morphine causes microbial dysbiosis. In this study we focused on restoration of native microbiota in morphine treated mice and looked at the extent of restoration and immunological consequences of this restoration. Fecal transplant has been successfully used clinically, especially for treating C. difficile infection2528. With our expanding knowledge of the central role of microbiome in maintenance of host immune homeostasis17, fecal transplant is gaining importance as a therapy for indications resulting from microbial dysbiosis. There is a major difference between fecal transplant being used for the treatment of C. difficile infection and the conditions described in our studies. The former strategy is based on the argument that microbial dysbiosis caused by disproportionate overgrowth of a pathobiont can be out-competed by re-introducing the missing flora by way of a normal microbiome transplant. This strategy is independent of host factors and systemic effects on the microbial composition. Here, we show that microbial dysbiosis caused due to morphine can be reversed by transplantation of microbiota from the placebo-treated animals.

2016-06-01 | E-MTAB-3723 | biostudies-arrayexpress

Project description:Stability of fecal samples for FMT

| PRJNA557215 | ENA